C6K Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Avalo Therapeutics Inc

Watchlist Manager

Watchlist

Price: 2.488 EUR 3.15%

Market Cap: €238.9m

	Avalo Therapeutics Inc F:C6K	US
D	Discover Financial Services DUS:DC7	US
	ING Groep NV LSE:0A2K	NL
F	Fairfax Financial Holdings Ltd F:FFX	CA
R	Restaurant Brands International Inc F:0R6	CA
A	Adidas AG OTC:ADDDF	DE
V	Vail Resorts Inc F:VAI	US
C	Corcept Therapeutics Inc XMUN:HTD	US
	Meituan F:9MD	CN

Profitability Summary

Avalo Therapeutics Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

100%

Strong 3Y Average Gross Margin

107%

Gross Margin is Increasing

86% > 100%

Negative Operating Margin

-123 602%

Negative 3Y Average Operating Margin

-20 575%

Declining Operating Margin

-122% > -123 602%

Negative Net Margin

-132 642%

Negative 3Y Average Net Margin

-23 421%

Declining Net Margin

-146% > -132 642%

Negative Free Cash Flow Margin

-87 217%

Negative 3Y Average Free Cash Flow Margin

-16 143%

Declining Free Cash Flow Margin

-115% > -87 217%

Negative ROE

-72%

Exceptional 3Y Average ROE

Negative 3Y Average ROIC

-298%

Declining ROIC

-115% > -428%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.